Management of Ventricular Septal Defect

Diagnostic Evaluation

A VSD typically presents with a holosystolic murmur over the third to fourth intercostal space, often with a palpable thrill, according to the European Heart Journal 1
In small VSDs, the physical examination may be normal except for the murmur, as noted in Circulation 2
In large VSDs with pulmonary hypertension, the murmur may be limited to early and midsystole, as reported in the Journal of the American College of Cardiology 3
Patients with severe pulmonary arterial hypertension (PAH) may have no murmur, a single loud second heart sound, and cyanosis/clubbing, according to Circulation 4
Echocardiography is the primary diagnostic tool, providing information on the severity of left ventricular volume overload, as stated in the European Heart Journal 1
Chest X-ray findings depend on defect size, with significant left-to-right shunt showing left atrial and LV enlargement with increased pulmonary vascular markings, as noted in Circulation 2 and 4

The European Society of Cardiology recommends surgical or catheter-based closure for patients with symptoms attributable to left-to-right shunting through the VSD who don't have severe pulmonary vascular disease 1
Asymptomatic patients with evidence of LV volume overload should undergo surgical or catheter-based closure, as recommended by the European Heart Journal 1
Patients with a history of infective endocarditis should undergo surgical or catheter-based closure, according to the European Heart Journal 1
The American Heart Association suggests that patients with VSD-associated prolapse of an aortic valve cusp causing progressive aortic regurgitation should undergo surgical or catheter-based closure 1
Patients with VSD and PAH when there is still net left-to-right shunt (Qp:Qs >1.5) and PAP or PVR are <2/3 of systemic values should undergo surgical or catheter-based closure, as recommended by Circulation 4

The American College of Cardiology recommends ACE inhibitors for AV valve regurgitation and symptoms of chronic heart failure 1
Diuretics (furosemide) should be used for volume management, as noted in Circulation 4

Regular echocardiographic assessment should be performed to monitor the development of aortic or tricuspid regurgitation, degree of residual shunt, left ventricular function, pulmonary artery pressure, development of double-chambered right ventricle, and development of discrete subaortic stenosis, as recommended by the European Heart Journal 1
Patients with LV dysfunction, residual shunt, PAH, aortic regurgitation, or outflow tract obstruction should be seen annually at specialized centers, according to the European Heart Journal 1

Small VSDs may be misdiagnosed as innocent murmurs, as noted in Circulation 2
Surgery should be avoided in Eisenmenger VSD and when exercise-induced desaturation is present, as recommended by the European Heart Journal 1
Heart failure in infants with VSDs may be misdiagnosed as pneumonia, according to Praxis Medical Insights 5
Development of complications such as aortic valve prolapse, double-chambered right ventricle, or subaortic stenosis requires vigilant monitoring, as stated in the European Heart Journal 1 and Praxis Medical Insights 5

The American College of Cardiology advises that ACE‑inhibitor therapy is indicated for infants with symptomatic heart failure due to large ventricular septal defects (e.g., failure to thrive or respiratory distress), but it is not recommended for small, asymptomatic muscular VSDs such as a 2 mm defect. 6

The European Society of Cardiology states that percutaneous closure with an Amplatzer Muscular VSD Occluder is technically feasible but should be reserved for large muscular VSDs that cause hemodynamic compromise; small defects (≤ 3 mm) do not meet criteria for device closure. 7

Structured echocardiographic surveillance for small muscular VSDs can be performed at intervals of 6–24 months in the absence of emerging hemodynamic abnormalities; more frequent imaging is warranted if signs of volume overload or valve regurgitation appear. 7

The European Society of Cardiology recommends antibiotic prophylaxis for all ventricular septal defects, regardless of size, to prevent infective endocarditis. 8
This recommendation is reinforced by the same European Heart Journal source that addresses device closure, confirming prophylaxis applies to both small muscular and perimembranous VSDs. 7